Skip to main content

FDA Panel Approves New Liver Drug

An FDA panel has recommended approval of a new drug aimed at treating a rare liver condition, the latest in a burgeoning field of liver-disease treatments.

Lead image for this article

An FDA panel has recommended approval of a new drug aimed at treating a rare liver condition, the latest in a burgeoning field of liver-disease treatments. The liver disease, primary biliary cirrhosis, destroys bile ducts in the liver and can lead to patients requiring liver transplants. (The Wall Street Journal)

Support public-service journalism that gets the context right

Yes, I'll donate today